Non-small Cell Lung Cancer study: Indocyanine green
Official title Near-Infrared Fluorescence Guided Robotic Pulmonary Segmentectomy for Early Stage Lung Cancer
ClinicalTrials.gov ID: NCT02570815
What this study is testing
What is Indocyanine Green?
An investigational fluorescent dye being studied for use in lung cancer surgery to help identify lung segments during resection.
Also referred to as IC-Green.
Plain-language explanation of the investigational treatment. It is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The study wants to see if the new near‑infrared fluorescence technique helps surgeons accurately remove the cancerous segment while sparing healthy lung tissue.
- Who it's for
- It is looking for adults with small non‑small cell lung cancers that are located in a single lung segment.
- What's involved
- Participants will have a robotic surgery. A dye is injected into a vein so the healthy lung lights up green, making the cancer‑free segment dark. The surgeon removes the dark segment and a pathologist checks the tissue to confirm the tumor is gone. If the tumor is not fully removed, a full lobectomy will be done instead.
- Time commitment
- The main commitment is one surgical procedure, with follow‑up visits as needed after surgery.
- Phase 1: an early, usually small safety study
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Age \> 18 years
- Tumor size \<3 cm
- Clinical Stage 1 Non-Small Cell Lung Cancer (NSCLC)
- CT-imaging confirming that the tumour is confined to the one broncho-pulmonary segment, rendering the patient a candidate for segmental resection.
You likely can't join if
- Hypersensitivity or allergy to ICG, sodium iodide or iodine
- Women who are currently pregnant or are breast feeding; or women of child bearing potential who are not currently taking adequate birth control.
The study team makes the final eligibility decision.
Where it is enrolling
- Hamilton, Ontario, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Hamilton, Ontario, Canada. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.